Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

May 13, 2019, 16:05 ET Milestone Pharmaceuticals Announces Closing of Initial Public Offering

Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing...


May 13, 2019, 10:50 ET Frost & Sullivan Publishes Annual Update on BioLineRx

The TASE analysis project was launched in 2016 in order to raise investor awareness to TASE listed technology and life-science companies and the...


May 13, 2019, 08:30 ET Liht Cannabis Corp. Announces First Product Sales and Closing of First Tranche of Private Placement

/NOT FOR DISSEMINATION OR DISTRIBUTION IN UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ KELOWNA, BC, May 13, 2019 /CNW/ - Liht Cannabis Corp....


May 13, 2019, 07:15 ET Canntrust Finalizes Letter of Intent With SQDC to Secure National Distribution

VAUGHAN, ON, May 13, 2019 /CNW/ - CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST; NYSE:CTST), today announced it has finalized a...


May 13, 2019, 07:00 ET Aurora Cannabis and Radient Technologies Announce First Commercial Delivery of Cannabis Derivatives

Transformational Milestone for Radient, Increasing Aurora's Global Derivative Market Capacity Substantially TSX: ACB | NYSE: ACB, TSXV: RTI EDMONTON, ...


May 13, 2019, 07:00 ET Kinaxis Spotlights the Power of Human and Machine Intelligence at Gartner Supply Chain Executive Conference

Joined by Kinaxis customers to present on their supply chain transformations OTTAWA and PHOENIX, AZ, May 13, 2019 /CNW/ - Kinaxis® Inc. (TSX: KXS),...


May 13, 2019, 03:00 ET Philogen Announces €62 Million Financing Round

Philogen S.p.A (or the "Company"), a clinical-stage biotechnology company focused on antibody-based therapeutics, today is pleased to announce a €62...


May 10, 2019, 15:19 ET Accelerating access to emergency treatments for patients, pets and livestock

Modernized programs will better meet the needs of patients and their healthcare professionals OTTAWA, May 10, 2019 /CNW/ - Canadians want improved...


May 10, 2019, 07:30 ET ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2019

HOUSTON, TX and VANCOUVER, May 10, 2019 /CNW/ - ESSA Pharma Inc. (TSX-V: EPI, NASDAQ: EPIX), a pharmaceutical company focused on developing novel...


May 10, 2019, 07:23 ET Pharmascience Inc. launches Royalmount Laboratories, a new analytical service division in Montreal

MONTREAL, May 10, 2019 /CNW Telbec/ - Pharmascience Inc. is proud to announce the launch of its new division in Montreal, Royalmount Laboratories....


May 10, 2019, 07:00 ET ADVANZ PHARMA Corp. Announces First Quarter 2019 Results

First quarter 2019 revenue of $136 million First quarter 2019 net loss of $8 million First quarter 2019 Adjusted EBITDA1 of $65 million Generated...


May 09, 2019, 07:00 ET Aurora Cannabis Extends Exclusive Supply Relationship with Luxembourg

TSX | NYSE: ACB EDMONTON, May 9, 2019 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM)...


May 09, 2019, 06:30 ET HLS Therapeutics Announces Q1 2019 Financial Results

Revenue of $13.2 million, Adjusted EBITDA of $8.3 million and Cash from Operations of $8.3 million Granted priority review status for Vascepa™ by...


May 09, 2019, 06:30 ET Endo Reports First-Quarter 2019 Financial Results

First-quarter 2019 revenues increased 3 percent to $720 million compared to first-quarter 2018 revenues of $701 million First-quarter 2019 Sterile...


May 08, 2019, 23:02 ET Milestone Pharmaceuticals Announces Pricing of Upsized Initial Public Offering

Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing...


May 08, 2019, 08:18 ET Mondias strengthens its management structure

MONTREAL, May 8, 2019 /CNW/ - Mondias Naturals Inc. ("Mondias" or the "Company") (TSXV: NHP) is pleased to announce the appointment of Mr. André...


May 08, 2019, 08:00 ET Correvio Reports First Quarter 2019 Financial Results

Mark H.N. Corrigan, MD Commences Role as CEO, effective March 14, 2019 Company on Track to Resubmit Brinavess NDA in Q2 2019 Management to Host...


May 08, 2019, 07:59 ET First and Only PARP Inhibitor, Lynparza® (Olaparib) Approved as a First-line Maintenance Therapy Treatment in BRCA-Mutated Advanced Ovarian Cancer

AstraZeneca and Merck's Lynparza reduced the risk of disease progression or death by 70% compared to placebo following response to platinum-based...


May 08, 2019, 07:25 ET InMed Pharmaceuticals to Report Third Quarter Fiscal 2019 Financial Results and Business Update on May 15, 2019

TSX:IN OTCQX:IMLFF VANCOUVER, BC, May 8, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a...


May 08, 2019, 06:00 ET Prevegyne®, the ONLY 6-day vaginal tablet treatment for non-specific vaginitis/bacterial vaginosis, now with the convenience of a vaginal applicator

BLAINVILLE, QC, May 8, 2019 /CNW Telbec/ - Duchesnay Inc., a company specializing in women's health, is proud to announce that Prevegyne® vaginal...


May 07, 2019, 09:47 ET RARECELLS DIAGNOSTICS Announces That Its Founder and Scientific Advisor, Professor Patrizia Paterlini-Bréchot, Is Named European Inventor Award 2019 Finalist

Rarecells Diagnostics, a leading company in the field of Liquid Biopsy, announces today that the European Patent Office (EPO) has nominated Professor ...


May 07, 2019, 09:08 ET Beleave's Hamilton Expansion Set for Consideration by Planning Committee on May 14

Beleave to add roughly 100,000 sq ft to Cannabis Growing and Harvesting Facility TORONTO, May 7, 2019 /CNW/ - Beleave Inc. (CSE: BE) (OTCQX: BLEVF)...


May 07, 2019, 09:00 ET Cannassure Completes Their Medical Cannabis Analytical Method Development and Validation in Accordance With the Israeli Medical Cannabis Agency (IMCA) Requirements

Cannassure Therapeutics (TASE: CSURE) announces another company milestone as they successfully complete their medical cannabis analytical method...


May 07, 2019, 08:30 ET Liht Cannabis Corp. Files Counterclaim against Veritas Pharma Inc.

KELOWNA, BC, May 7, 2019 /CNW/ - Liht Cannabis Corp. (CSE: LIHT) (OTCQX: LIHTF) ("Liht" or the "Company"), announces that it has filed a counterclaim ...


May 07, 2019, 08:00 ET Crescita Therapeutics Strengthens Leadership Team with New Vice-President in Aesthetic and Cosmeceutical Business Unit

LAVAL, QC, May 7, 2019 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (OTC US: CRRTF) (Crescita or the Company), a Canadian commercial dermatology...